Jupiter Life Line Hospitals IPO Details
IPO Date	September 6, 2023 to September 8, 2023
Listing Date	September 18, 2023
Face Value	₹10 per share
Issue Price Band	₹695 to ₹735 per share
Issue Price Final	₹735 per share
Lot Size	20 Shares
Sale Type	Fresh Capital-cum-Offer for Sale
Total Issue Size	1,18,24,163 shares
(aggregating up to ₹869.08 Cr)
Fresh Issue	73,74,163 shares
(aggregating up to ₹542.00 Cr)
Offer for Sale	44,50,000 shares of ₹10
(aggregating up to ₹327.08 Cr)
Issue Type	Bookbuilding IPO
Listing At	BSE, NSE
Share Holding Post Issue	6,55,66,022 shares
Jupiter Life Line Hospitals IPO Reservation
Jupiter Life Line Hospitals IPO offers total 1,18,24,163 shares. Out of which 59,12,080 (50.00%) allocated to QIB, 23,64,833 (20.00%) allocated to QIB, 17,73,625 (15.00%) allocated to NII, 41,38,458 (35.00%) allocated to RII and 35,47,247 (30.00%) allocated to Anchor investors.

Investor Category	Shares Offered	Maximum Allottees
QIB Shares Offered	59,12,080 (50.00%)	NA
NII (HNI) Shares Offered	17,73,625 (15.00%)	NA
Retail Shares Offered	41,38,458 (35.00%)	2,06,922
Total Shares Offered	1,18,24,163 (100.00%)	
Jupiter Life Line Hospitals IPO Anchor Investors Details
Jupiter Life Line Hospitals IPO raises ₹260.72 crore from anchor investors. Jupiter Life Line Hospitals IPO Anchor bid date is September 5, 2023. Jupiter Life Line Hospitals IPO Anchor Investors list

Bid Date	September 5, 2023
Shares Offered	35,47,247
Anchor Portion Size (In Cr.)	260.72
Anchor lock-in period end date for 50% shares (30 Days)	October 13, 2023
Anchor lock-in period end date for remaining shares (90 Days)	December 12, 2023
Jupiter Life Line Hospitals IPO Timeline (Tentative Schedule)
Jupiter Life Line Hospitals IPO opens on September 6, 2023, and closes on September 8, 2023.

IPO Open Date	Wed, Sep 6, 2023
IPO Close Date	Fri, Sep 8, 2023
Tentative Allotment	Wed, Sep 13, 2023
Initiation of Refunds	Thu, Sep 14, 2023
Credit of Shares to Demat	Fri, Sep 15, 2023
Tentative Listing Date	Mon, Sep 18, 2023
Cut-off time for UPI mandate confirmation	5 PM on Fri, Sep 8, 2023
Jupiter Life Line Hospitals IPO Lot Size
Investors can bid for a minimum of 20 shares and in multiples thereof.  The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.

Application	Lots	Shares	Amount
Retail (Min)	1	20	₹14,700
Retail (Max)	13	260	₹1,91,100
S-HNI (Min)	14	280	₹2,05,800
S-HNI (Max)	68	1,360	₹9,99,600
B-HNI (Min)	69	1,380	₹10,14,300
Jupiter Life Line Hospitals IPO Promoter Holding
Dr. Ajay Thakker, Dr. Ankit Thakker, and Western Medical Solutions LLP are the promoters of the company.
Promoter Holding Pre Issue	49.79%
Promoter Holding Post Issue	40.91%
Note : The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue

About Jupiter Life Line Hospitals Ltd.
Incorporated in 2007, Jupiter Life Line Hospitals Limited is a multi-specialty tertiary and quaternary healthcare provider in the Mumbai Metropolitan Area (MMR) and western region of India.

Jupiter Life Line Hospitals has been operating as a corporate quaternary care healthcare service provider in the western regions of India and currently operates three hospitals under the "Jupiter" brand in Thane, Pune, and Indore, with a total operational bed capacity of 1194 beds, and 1,306 doctors including specialists, physicians, and surgeons, as of March 31, 2023. The company is currently developing a multi-specialty hospital in Dombivli, Maharashtra, which is designed to accommodate over 500 beds and has commenced construction in April 2023.

According to the CRISIL Report, the company's Thane and Indore hospitals are amongst the few hospitals in the western region of India to provide neuro-rehabilitation services through a dedicated robotic and computer-assisted neuro-rehabilitation center. Additionally, it operates one of the few multi-organ transplant centers in Thane. All the hospitals in Thane, Pune, and Indore have been certified by the National Accreditation Board for Hospitals & Healthcare Providers (NABH) and have been accredited in the field of medical testing by the National Accreditation Board for Testing and Calibration Laboratories (NABL).

The company's inpatient and outpatient revenue is diversified across hospitals with Thane, Pune, and Indore hospitals accounting for 54.18%, 34.03%, and 11.79%, respectively, of the revenue from operations in Fiscal 2023.

Company Financials
Jupiter Life Line Hospitals IPO Financial Information (Restated Consolidated)
Period Ended	31 Mar 2021	31 Mar 2022	31 Mar 2023
Assets	788.91	908.70	985.53
Total Income	490.27	737.14	902.96
Profit After Tax	-2.30	51.13	72.91
Net Worth	246.44	288.43	363.91
Reserves and Surplus			
Total Borrowing	425.52	495.25	468.63
Amount in ₹ Crore
Key Performance Indicator (KPI)
The market capitalization of Jupiter Life Line Hospitals IPO is ₹4819.10 Cr.

KPI	Values
ROE	20.03%
ROCE	20.94%
RoNW	20.03%
Check Jupiter Life Line Hospitals IPO Peer Comparison here.
Pre IPO	Post IPO
EPS Rs	13.95	
P/E (x)	52.68	66.1
Objects of the Issue (Jupiter Life Line Hospitals IPO Objectives)
The Company Jupiter Life Line Hospitals IPO proposes to utilise the Net Proceeds from the Issue towards the following objects:

S.No.	Objects of the Issue	Expected Amount (₹ in crores)
1	Repayment/pre-payment, in full or part, of borrowings availed from banks by the Company and Material Subsidiary;and	510.16
2	General corporate purposes	1.16
Jupiter Life Line Hospitals IPO Review
[Dilip Davda]  JLLHL is a known chain of Hospitals in the MMR regions and gaining preference due to its high-tech and advanced healthcare services with ultramodern diagnostic services. Based on FY23 earnings, the issue appears fully priced. Post Covid, preference for better-equipped healthcare centres is on the rise and this company is rightly placed in that category. The company also has plans to expand its footprint in the Western Regions. Considering the fancy for the branded chain of hospitals, investors may consider investment for the medium to long term in this issue. Read detail review...

Jupiter Life Line Hospitals IPO Subscription Status (Bidding Detail)
The Jupiter Life Line Hospitals IPO is subscribed 64.8 times on September 8, 2023 7:02:00 PM (Day 3). The public issue subscribed 8 times in the retail category, 181.89 times in the QIB category, and 36 times in the NII category. Check Day by Day Subscription Details (Live Status)

Category	Subscription (times)	Shares Offered	Shares bid for
QIB	181.89	24,43,743	44,44,94,800
NII	36	17,73,625	6,38,46,320
    bNII (bids above ₹10L)	40.64	11,82,416	4,80,57,860
    sNII (bids below ₹10L)	26.71	5,91,209	1,57,88,460
Retail	8	41,38,458	3,31,19,240
Total	64.8	83,55,826	54,14,60,360
Total Application : 14,60,441

Jupiter Life Line Hospitals IPO Prospectus
  ›  Jupiter Life Line Hospitals IPO DRHP
  ›  Jupiter Life Line Hospitals IPO RHP
  ›  Anchor Investors in Jupiter Life Line Hospitals IPO
  ›  Jupiter Life Line Hospitals IPO Final Prospectus
Jupiter Life Line Hospitals IPO Listing Details
Listing Date	September 18, 2023
BSE Script Code	543980
NSE Symbol	JLHL
ISIN	INE682M01012
Final Issue Price	₹735 per share
BSE Listing Group	B (Rolling)
Pre-Open Session - NSEPre-Open Session - BSE

Listing Day Trading Information
Price Details	NSE SME	NSE SME
Final Issue Price	₹735.00	₹735.00
Open	₹960.00	₹973.00
Low	₹960.00	₹970.00
High	₹1,107.50	₹1,108.95
Last Trade	₹1,075.25	₹1,075.75